Decolonizing global health research: A checklist for equity
Global health equity means more than working toward good health around the world. It also means fairness for researchers.
Jan 23, 2023
0
25
Global health equity means more than working toward good health around the world. It also means fairness for researchers.
Jan 23, 2023
0
25
Trouble continues for Abbott Laboratories, which shut down an infant formula plant last year amid reported illnesses.
Jan 23, 2023
0
2
The success of the Optimise Study in shaping Victoria's and Australia's response to the COVID-19 pandemic paves the way for similarly ambitious research projects in the future, a webinar wrapping up the project was told.
Jan 17, 2023
0
17
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug ...
Dec 7, 2022
0
540
Experiments conducted in Brazil by researchers at the State University of Campinas (UNICAMP) and the University of São Paulo (USP) showed that visceral fat—fat around the liver, intestines and other organs, considered ...
Dec 6, 2022
0
84
The field of genomic science is rapidly advancing, with commercial genetic tests becoming affordable and popular.
Nov 29, 2022
0
3
Thirdhand smoke, or THS, comprises the residual pollutants from tobacco smoke that remain on surfaces and in dust after tobacco has been smoked. It can remain on indoor surfaces indefinitely, causing potentially harmful exposure ...
Oct 11, 2022
0
99
An investigational drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) reduced molecular signs of the fatal, paralyzing disease and curbed neurodegeneration—but at six months, the drug ...
Sep 21, 2022
0
50
For years, apremilast (brand name Otezla) has helped psoriasis patients achieve clearer skin and ease the symptoms of their psoriatic arthritis. Now, new data from researchers at the Perelman School of Medicine at the University ...
Sep 21, 2022
0
4
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2